Recent Financial News:More >>
22 July 2010
Elan Reports Second Quarter and First Half 2010 Financial Results| DUBLIN, Jul 22, 2010 (BUSINESS WIRE) -- Elan Corporation, plc today reported its second quarter and first half 2010 financial results.
Elan CEO Kelly Martin commented, "Our second quarter results demonstrate continued progress across our major areas of focus. Tysabri growth increased in terms of net patient additions; our BioNeurology pipeline advanced, including completion of the ELND005 Phase 2 trial and full enrollment of the STRATIFY 1 trial studying the JC virus assay; we also saw recen... |
| 15 July 2010
Elan Corporation, plc Reaches Agreement in Principle for Settlement
of Investigation of Past Zonegran Sales and Marketing Activities| Elan establishes $206.3 million reserve for expected settlement
DUBLIN, Jul 15, 2010 (BUSINESS WIRE) --Elan Corporation, plc (NYSE: ELN) today announced that it has reached an
agreement in principle with the United States Attorney's Office for the
District of Massachusetts with respect to the previously disclosed U.S.
Department of Justice's investigation of sales and marketing practices
for Zonegran (zonisamide), an antiepileptic prescription medicine that
... |
| 08 July 2010
Elan Announces Webcast of Second Quarter 2010 Financial Results| DUBLIN, Jul 08, 2010 (BUSINESS WIRE) --Elan Corporation, plc (NYSE:ELN) announced today that it will host a
conference call on Thursday, July 22, at 8:30 a.m. Eastern Time (ET),
1:30 p.m. GMT with the investment community to discuss Elan's second
quarter 2010 financial results, which will be released before the
European and U.S. financial markets open.
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be ava... |
| 06 July 2010
Eliseo O. Salinas, MD, MSc Joins Elan as Executive Vice President and
Chief Medical Officer| DUBLIN, Jul 06, 2010 (BUSINESS WIRE) --Elan Corporation, plc (NYSE: ELN) today announced that Eliseo Oreste
Salinas, MD, MSc, has joined the company as Executive Vice President and
Chief Medical Officer effective immediately, with responsibility for
leading the company's global development, clinical and medical
initiatives. Dr. Salinas will be based at Elan's South San Francisco
campus, will be a member of the company's executive leadership team, and
... |
|
 |
Upcoming Events:More >>
| There are currently no events scheduled. |
Receive E-mail Alerts | | Sign up to receive e-mail alerts whenever Elan Corporation, PLC posts new information to the site. Just enter your e-mail address and click Submit. |
|
RSS Feeds | 
E-mail Alerts | 
Contact IR